Author: Dorian Fitzwilliam - Page 2

1Dec

How Conjugated Estrogens USP May Influence Autoimmune Diseases

Posted by Dorian Fitzwilliam 5 Comments

Conjugated estrogens USP may worsen autoimmune diseases like lupus and Sjögren’s syndrome, while having mixed effects on rheumatoid arthritis. Learn how estrogen impacts immune function and what safer alternatives exist.

1Dec

Flibanserin: What It Really Does for Low Sexual Desire in Women

Posted by Dorian Fitzwilliam 4 Comments

Flibanserin is not a fertility drug - it's for low sexual desire in premenopausal women. Learn what it actually does, who it helps, and why it won't help you get pregnant.

1Dec

Therapeutic Equivalence: What It Really Means for Patient Safety

Posted by Dorian Fitzwilliam 5 Comments

Therapeutic equivalence ensures generic drugs work just like brand-name ones, keeping patients safe and saving billions. Learn how the FDA verifies this, why it matters, and what to watch for when switching medications.

27Nov

Physical Therapy for Pain: Exercise, Stretching, and Restoration

Posted by Dorian Fitzwilliam 7 Comments

Physical therapy for pain uses exercise, stretching, and movement to reduce chronic pain without drugs. Proven methods include walking, tai chi, and targeted strength routines. Learn how to start safely and see real results in weeks.

26Nov

Oral vs Injection vs Topical: How Drug Delivery Routes Affect Side Effects

Posted by Dorian Fitzwilliam 11 Comments

Learn how oral, injection, and topical drug routes affect side effects differently. Discover why some medications cause stomach issues, others cause skin reactions, and how delivery method changes your risk.

25Nov

Global Biosimilar Markets: Europe vs United States - How Regulations and Adoption Diverge

Posted by Dorian Fitzwilliam 9 Comments

Europe led the world in biosimilar adoption with clear regulations and fast uptake. The U.S. lagged due to legal barriers and strict rules - but is now catching up fast. Here's how the two markets compare today and where they're headed.

23Nov

Sick Day Rules for Diabetes: How to Manage Insulin, Hydration, and Ketone Checks When You're Ill

Posted by Dorian Fitzwilliam 13 Comments

When you're sick with diabetes, managing insulin, hydration, and ketones is critical to avoid life-threatening complications. Learn the updated sick day rules for Type 1 and Type 2 diabetes, what to do when blood sugar spikes, and when to seek emergency care.

22Nov

Lot Number Tracking: How the FDA Identifies Problem Batches in the Food Supply

Posted by Dorian Fitzwilliam 12 Comments

The FDA uses traceability lot codes to quickly track contaminated food batches through the supply chain, cutting outbreak response time from weeks to hours. Learn how this system protects your food safety.

21Nov

Antitrust Laws and Competition Issues in Generic Pharmaceutical Markets

Posted by Dorian Fitzwilliam 11 Comments

Antitrust laws in the generic drug market aim to prevent pay-for-delay deals, patent abuse, and product hopping that block cheaper medications. These practices cost patients billions and delay access to life-saving drugs.

20Nov

DOACs in Renal Impairment: How to Adjust Dosing to Prevent Bleeding and Clots

Posted by Dorian Fitzwilliam 14 Comments

DOACs like apixaban, rivaroxaban, and dabigatran require precise dosing in kidney disease to avoid bleeding or strokes. Learn which drug is safest, how to calculate kidney function correctly, and what doses to use based on real-world data.